8h
Hosted on MSNGLP-1 Drugs and Colonoscopy; GI Symptoms Post-COVID; Identifying High-Risk Barrett'sA systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...
The use of glucagon-like peptide-1 receptor agonists is likely to increase the risks of inadequate bowel preparation for colonoscopy, according to a study published Feb. 12 in The American Journal of ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
12h
Hosted on MSNZealthy vs Ro: Which Weight Loss Plan Works Best?Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results